KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001815308-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
11,767
Total Value
$27,506.54
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 21, 2026 | Exercise/Conversion | 5,000 | โ | โ | 15,529 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 23, 2026 | Sale | 1,767 | $15.57 | $27,506.54 | 13,762 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Unit | Derivative | Feb 21, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 60,000 | Direct | โ | View Details |